The GAVI Alliance has committed $100 million to support a meningitis A vaccine called MenAfriVac developed by Seattle-based PATH. The vaccine, which was developed with the help of a $70 million donation from the Bill and Melinda Gates Foundation, has already been introduced in Burkina Faso, Mali and Niger. The funding includes $72.6 million to purchase MenAfriVac vaccines and $27.6 million for operational costs. Release